Literature DB >> 7532420

Characterization of the mechanism involved in bleomycin-induced increased hyaluronan production in rat lung.

P Teder1, O Nettelbladt, P Heldin.   

Abstract

The molecular mechanisms behind the accumulation of hyaluronan during bleomycin-induced lung injury in rats were investigated. The stimulatory effects of bronchoalveolar lavage fluid (BALF) and alveolar macrophage (AM)-conditioned media on hyaluronan synthesis in normal rat lung fibroblast cultures were studied as well as the hyaluronan binding activity on AM. BALF obtained on days 1 and 5 after bleomycin instillation exhibited hyaluronan stimulatory activity similar to that of 10% fetal serum; the activity returned to control values on day 14 after bleomycin treatment. Conditioned media from cultures of AM obtained from bleomycin-treated rats exhibited stimulatory effects higher than that of media from AM of control rats and equal to or higher than that of 10% fetal calf serum. The stimulatory activity in BALF was significantly inhibited by neutralizing antibodies against transforming growth factor-beta; the activity in AM-conditioned media was only partially affected. Neutralizing antibodies against platelet-derived growth factor-BB or -AA had no such inhibiting effect. Interestingly, AM from bleomycin-treated rats exhibited low hyaluronan binding activity. [3H]Hyaluronan binding by AM on days 1 and 5 after bleomycin administration was about 2-fold and 4-fold lower, respectively, compared with that by AM derived from saline-treated rats. This decrease was normalized 14 days after bleomycin treatment. In conclusion, our results indicate that factors with high potential to stimulate hyaluronan synthesis in rat lung fibroblasts are accumulated in BALF from bleomycin-treated rats and that AM are likely to be one source of such stimulatory factors.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7532420     DOI: 10.1165/ajrcmb.12.2.7532420

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  8 in total

1.  The chemokine CCL18 causes maturation of cultured monocytes to macrophages in the M2 spectrum.

Authors:  Ingrid U Schraufstatter; Ming Zhao; Sophia K Khaldoyanidi; Richard G Discipio
Journal:  Immunology       Date:  2012-04       Impact factor: 7.397

Review 2.  Modulators of inflammation in Bronchopulmonary Dysplasia.

Authors:  Rashmin C Savani
Journal:  Semin Perinatol       Date:  2018-10-02       Impact factor: 3.300

Review 3.  Hyaluronan as an immune regulator in human diseases.

Authors:  Dianhua Jiang; Jiurong Liang; Paul W Noble
Journal:  Physiol Rev       Date:  2011-01       Impact factor: 37.312

4.  Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury.

Authors:  Aisha Zaman; Zheng Cui; Joseph P Foley; Hengjiang Zhao; Paul C Grimm; Horace M Delisser; Rashmin C Savani
Journal:  Am J Respir Cell Mol Biol       Date:  2005-07-21       Impact factor: 6.914

5.  Toll-like receptor 2 (TLR2), transforming growth factor-β, hyaluronan (HA), and receptor for HA-mediated motility (RHAMM) are required for surfactant protein A-stimulated macrophage chemotaxis.

Authors:  Joseph P Foley; David Lam; Hongmei Jiang; Jie Liao; Naeun Cheong; Theresa M McDevitt; Aisha Zaman; Jo Rae Wright; Rashmin C Savani
Journal:  J Biol Chem       Date:  2012-09-04       Impact factor: 5.157

6.  The Receptor for Hyaluronan-Mediated Motility (CD168) promotes inflammation and fibrosis after acute lung injury.

Authors:  Zheng Cui; Jie Liao; Naeun Cheong; Christopher Longoria; Gaoyuan Cao; Horace M DeLisser; Rashmin C Savani
Journal:  Matrix Biol       Date:  2018-08-08       Impact factor: 11.583

7.  Hyaluronan fragments activate an NF-kappa B/I-kappa B alpha autoregulatory loop in murine macrophages.

Authors:  P W Noble; C M McKee; M Cowman; H S Shin
Journal:  J Exp Med       Date:  1996-05-01       Impact factor: 14.307

Review 8.  The Rise and Fall of Hyaluronan in Respiratory Diseases.

Authors:  Mark E Lauer; Raed A Dweik; Stavros Garantziotis; Mark A Aronica
Journal:  Int J Cell Biol       Date:  2015-09-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.